Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis

OBJECTIVE: To examine whether rituximab induction followed by glatiramer acetate (GA) monotherapy is more effective than GA alone for the treatment of relapsing multiple sclerosis with active disease. METHODS: This was a single-center, double-blind, placebo-controlled study. Fifty-five participants...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurology
Hlavní autoři: Honce, Justin M., Nair, Kavita V., Sillau, Stefan, Valdez, Brooke, Miravalle, Augusto, Alvarez, Enrique, Schreiner, Teri, Corboy, John R., Vollmer, Timothy L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382366/
https://ncbi.nlm.nih.gov/pubmed/30635477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006916
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky